KLRC1 Antibody (C-term) Blocking Peptide

Catalog Number: ABT-BP8629B
Article Name: KLRC1 Antibody (C-term) Blocking Peptide
Biozol Catalog Number: ABT-BP8629B
Supplier Catalog Number: BP8629b
Alternative Catalog Number: ABT-BP8629B-500UG
Manufacturer: Abcepta
Category: Proteine/Peptide
Alternative Names: NKG2-A/NKG2-B type II integral membrane protein, CD159 antigen-like family member A, NK cell receptor A, NKG2-A/B-activating NK receptor, CD159a, KLRC1, NKG2A
Natural killer (NK) cells are lymphocytes that can mediate lysis of certain tumor cells and virus-infected cells without previous activation. They can also regulate specific humoral and cell-mediated immunity. This protein belongs to the killer cell lectin-like receptor family, also called NKG2 family, which is a group of transmembrane proteins preferentially expressed in NK cells. This family of proteins is characterized by the type II membrane orientation and the presence of a C-type lectin domain. This protein forms a complex with another family member, KLRD1/CD94, and has been implicated in the recognition of the MHC class I HLA-E molecules in NK cells.
NCBI: 3821
UniProt: P26715
Form: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target: The synthetic peptide sequence used to generate the antibody AP8629b was selected from the C-term region of human KLRC1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.